Marquis Unveiled
The first FDA-approved treatment for equine protozoal myeloencephalitis (EPM), Marquis, was launched Aug. 23 at Bayer’s headquarters in Kansas City, Mo. Robert MacKay, BVSc, PhD, Dipl. ACVIM, of the University of Florida College of Veterinary



